Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of AC682 for the Treatment of Locally Advanced or Metastatic ER+ Breast Cancer

Accutar Biotechnology Inc · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
breastcancer
breast cancer, estrogen receptor positive, er positive, er+, human epidermal growth factor receptor 2 negative, her2 negative, her2-, ac682, phase i, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 886518
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.